Gastric Reflux
Conditions
Brief summary
A study comparing the effect of two doses of neostigmine on the gastric residual volume in critically ill patients on enteral feeding.
Detailed description
Participants were categorized into three groups: Group I and Group II received neostigmine 1 mg and 2 mg, respectively, and a control group received 10 ml of normal saline. All participants received an intravenous administration of 10 mg of metoclopramide. GRV was measured every 3 hours before enteral feeding. aspiration through nasogastric (NG) or orogastric (OG) tubes was done before the next due bolus of feeding.
Interventions
DRUGNeostigmine
two groups (Group I, n= 41) and (Group II, n= 43) received varying doses of neostigmine (1 mg and 2 mg respectively
Sponsors
Zulekha Hospitals
Study design
Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
* patients with a GRV \>120ml * a normal heart rate
Exclusion criteria
* absence of comorbidities such as diabetes and renal failure.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The risk of aspiration | december 2022 to may 2024 | The risk of aspiration in ICU patients on enteral feeding via vaso-gastric or oro-hastric tubes |
Countries
Egypt
Outcome results
None listed